长效干扰素:聚乙二醇干扰素研究进展

被引:44
作者
马慧
王豪
机构
[1] 北京大学人民医院肝病研究所,北京大学人民医院肝病研究所,
关键词
干扰素; 聚乙二醇于扰素; 肝炎,丙型;
D O I
暂无
中图分类号
R965 [实验药理学];
学科分类号
摘要
引用
收藏
页码:78 / 79
页数:2
相关论文
共 6 条
[1]  
Relationship of effective molecularsize to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers. Knauf MJ,Bell DP,Hirtzer P. et al. Journal of Biological Chemistry . 1988
[2]  
Polymer Syntheses. Sandler SR,Karo W,ed. . 1980
[3]  
The pharmacokinetics of pegylated-40 K interferon in chronic hepatitis C patients with cirrhosis. Heathcote EJ,Pockros P,Fried M,et al. Gastroenterology . 1999
[4]  
Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model. Katre NV,Knauf MJ,Laird WJ. Proceedings of the National Academy of Sciences of the United States of America . 1987
[5]  
Response of dogs to repeated intravenous injection of polyethylene glycol 4000. Carpenter CP,Woodside MD. Kinkead ER,et al. Toxicology and Applied Pharmacology . 1971
[6]  
A controlled, randomized multicenter, descending dose phase Ⅱ trial of pegylated interferon α-2a(PEG) vs standard interferonα-2a(IFN) for treatment of chronic hepatitis C. Schiffman M,Pockros PJ,Reddy RK,et al. Gastroenterology . 1999